X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
aged (10) 10
clinical neurology (9) 9
female (9) 9
male (7) 7
middle aged (7) 7
peripheral vascular disease (7) 7
tissue plasminogen activator - administration & dosage (6) 6
treatment outcome (6) 6
acute disease (5) 5
fibrinolytic agents - administration & dosage (5) 5
fibrinolytic agents - adverse effects (5) 5
fibrinolytic agents - therapeutic use (5) 5
thrombolytic therapy (5) 5
tissue plasminogen activator - adverse effects (5) 5
tissue plasminogen activator - therapeutic use (5) 5
recombinant proteins - therapeutic use (4) 4
therapy (4) 4
alteplase (3) 3
cerebrovascular disorders - therapy (3) 3
injections, intravenous (3) 3
intravenous thrombolysis (3) 3
original paper (3) 3
recombinant proteins - administration & dosage (3) 3
risk factors (3) 3
stroke - drug therapy (3) 3
stroke - mortality (3) 3
stroke, acute (3) 3
time factors (3) 3
acute ischemic stroke (2) 2
acute ischemic-stroke (2) 2
adult (2) 2
anaphylaxis - chemically induced (2) 2
anaphylaxis - immunology (2) 2
brain ischemia - drug therapy (2) 2
cerebrovascular disorders - diagnosis (2) 2
drug hypersensitivity - diagnosis (2) 2
drug hypersensitivity - immunology (2) 2
ecass (2) 2
ecology (2) 2
embolic stroke (2) 2
follow-up studies (2) 2
immunoglobulin e - blood (2) 2
index medicus (2) 2
national institutes of health - standards (2) 2
neurologic examination - standards (2) 2
neurologic examination - statistics & numerical data (2) 2
observer variation (2) 2
prospective studies (2) 2
reliability (2) 2
reproducibility of results (2) 2
rt-pa (2) 2
stroke (2) 2
tissue-plasminogen activator (2) 2
tissue-plasminogen-activator (2) 2
tpa (2) 2
united states (2) 2
academic medical centers (1) 1
academic medical centers - statistics & numerical data (1) 1
acquired thermotolerance (1) 1
activities of daily living (1) 1
acute stroke (1) 1
adaptation, physiological (1) 1
agriculture (1) 1
analysis (1) 1
anaphylaxis (1) 1
animal behavior (1) 1
antibodies (1) 1
anticoagulants (1) 1
antiplatelet therapy (1) 1
arabidopsis (1) 1
arabidopsis-thaliana (1) 1
arterial occlusive diseases - complications (1) 1
arterial occlusive diseases - diagnostic imaging (1) 1
arterial occlusive diseases - drug therapy (1) 1
arterial occlusive diseases - therapy (1) 1
aspirin (1) 1
aspirin - administration & dosage (1) 1
aspirin - adverse effects (1) 1
aspirin - therapeutic use (1) 1
atlantis (1) 1
bacterial physiological phenomena (1) 1
basilar artery-occlusion (1) 1
bet hedging (1) 1
biological evolution (1) 1
biology (1) 1
biomass (1) 1
brain (1) 1
brain ischemia - complications (1) 1
brain ischemia - etiology (1) 1
brain ischemia - mortality (1) 1
carbon (1) 1
carotid artery diseases - complications (1) 1
carotid artery diseases - diagnostic imaging (1) 1
carotid artery diseases - therapy (1) 1
carotid artery dissection (1) 1
carotid artery occlusion (1) 1
cerebral arterial diseases - drug therapy (1) 1
cerebrovascular disorders - complications (1) 1
cerebrovascular disorders - diagnostic imaging (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cerebrovascular Diseases, ISSN 1015-9770, 07/2003, Volume 16, Issue 3, pp. 183 - 190
Journal Article
Cerebrovascular Diseases, ISSN 1015-9770, 06/2007, Volume 24, Issue 1, pp. 56 - 65
Journal Article
The Lancet, ISSN 0140-6736, 11/1997, Volume 350, Issue 9091, pp. 1595 - 1596
Journal Article
Stroke, ISSN 0039-2499, 1999, Volume 30, Issue 5, pp. 1142 - 1143
Background and Purpose-Although alteplase, a recombinant tissue plasminogen activator (tPA), is structurally identical to endogenous tPA and therefore should... 
Antibodies | Alteplase | Anaphylaxis | PERIPHERAL VASCULAR DISEASE | anaphylaxis | antibodies | alteplase | CLINICAL NEUROLOGY
Journal Article
Journal Article
European Journal of Neurology, ISSN 1351-5101, 01/1999, Volume 6, Issue 1, pp. 51 - 55
Between March 1996 and December 1997, 15 consecutive patients with carotid artery occlusion diagnosed with duplex sonography were treated with intravenous... 
intravenous thrombolysis | rt‐PA | carotid artery dissection | alteplase | ischemic stroke | carotid artery occlusion | Carotid artery occlusion | Alteplase | Ischemic stroke | Intravenous thrombolysis | Carotid artery dissection | rt-PA | FIRST-LINE TREATMENT | NEUROSCIENCES | CLINICAL NEUROLOGY | THERAPY | TISSUE-PLASMINOGEN-ACTIVATOR | ACUTE ISCHEMIC STROKE | EMBOLIC STROKE | Recombinant Proteins - therapeutic use | Intracranial Thrombosis - complications | Injections, Intravenous | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Intracranial Thrombosis - therapy | Tissue Plasminogen Activator - therapeutic use | Contraindications | Carotid Artery Diseases - diagnostic imaging | Fibrinolytic Agents - therapeutic use | Ultrasonography | Adult | Female | Stroke - mortality | Intracranial Arteriosclerosis - diagnostic imaging | Stroke - therapy | Arterial Occlusive Diseases - diagnostic imaging | Tissue Plasminogen Activator - administration & dosage | Recombinant Proteins - administration & dosage | Carotid Artery Diseases - therapy | Stroke - etiology | Thrombolytic Therapy | Aged | Fibrinolytic Agents - administration & dosage | Arterial Occlusive Diseases - complications | Intracranial Arteriosclerosis - therapy | Arterial Occlusive Diseases - therapy | Intracranial Arteriosclerosis - complications | Intracranial Thrombosis - diagnostic imaging
Journal Article
International Journal of Clinical Practice, Supplement, ISSN 1368-504X, 04/2003, Issue 136, pp. 37 - 40
Journal Article
Stroke, ISSN 0039-2499, 1998, Volume 29, Issue 6, pp. 1258 - 1259
Journal Article
Cerebrovascular Diseases, ISSN 1015-9770, 06/2007, Volume 24, Issue 1
Journal Article
Cerebrovascular Diseases, ISSN 1015-9770, 06/2007, Volume 24, Issue 1, pp. 160 - 160
Journal Article
Cerebrovascular Diseases, ISSN 1015-9770, 06/2007, Volume 24, Issue 1
Journal Article
Stroke, ISSN 0039-2499, 05/1999, Volume 30, Issue 5, p. 1142
Although alteplase, a recombinant tissue plasminogen activator (tPA), is structurally identical to endogenous tPA and therefore should not induce allergy,... 
Fibrinolytic Agents - adverse effects | Anaphylaxis - chemically induced | Drug Hypersensitivity - immunology | Humans | Anaphylaxis - immunology | Drug Hypersensitivity - diagnosis | Female | Aged | Immunoglobulin E - blood | Tissue Plasminogen Activator - adverse effects
Journal Article
by Melander, A and Olsson, J and Lindberg, G and Salzman, A and Howard, T and Stang, P and Lydick, E and Emslie-Smith, A and Boyle, D I. R and Evans, J M. M and Macdonald, T M and Bain, J and Sullivan, F and Juhl, C and Pørksen, N and Sturis, J and Hollingdal, M and Pincus, S and Veldhuis, J and Dejgaard, A and Schmitz, O and Kristensen, J S and Frandsen, K B and Bayer, Th and Müller, P and Dunning, B E and Paladini, S and Gutierrez, C and Deacon, R and Valentin, M and Grunberger, G and Weston, W M and Patwardhan, R and Rappaport, E B and Sargeant, L A and Wareham, N J and Khaw, K T and Zethelius, Björn and Lithell, Hans and Hales, C Nicholas and Berne, Christian and Lakka, H.-M and Oksanen, L and Tuomainen, T.-P and Kontula, K and Salonen, J T and Dekker, J M and de Boks, P and de Vegt, F and Stehouwer, C D. A and Nijpels, G and Bouter, L M and Heine, R J and Bruno, G and Cavallo-Perin, P and Bargero, G and D’Errico, N and Borra, M and Macchia, G and Pagano, G and Newton, R W and Ruta, D A and New, J P and Wallace, C and Roxburgh, M A and Young, R J and Vaughan, N J. A and Elliott, P and Brennan, G and Devers, M and MacAlpine, R and Steinke, D and Lawson, D H and Decallonne, B and Casteels, K and Gysemans, C and Bouillon, R and Mathieu, C and Linn, Thomas and Strate, Christine and Schneider, Kerstin and Funda, D P and Jirsa Jr, M and Kozáková, H and Kaas, A and Kofronová, O and Tlaskalová-Hogenová, H and Buschard, K and Wanka, H and Hartmann, A and Kuttler, B and Rasmussen, S B and Sørensen, T S and Markholst, H and Petersen, J S and Karounos, D and Dyrberg, T and Mabley, J G and Haskó, G and Szabó, C and ... and IMDIAB Study Group and Osaka IDDM Study Group and European Group for the Study of Insulin Resistance (EGIR) and Screen-Pol Study Group and Northern Diabetic Pregnancy Survey and Brazilian Gestational Diabetes Study Group and UK Prospective Diabetes Study Group and Hungarian HbA1c Screening Study Group and Croatian Study Group for Diabetic Amyotrophy and EURODIAB IDDM Study Group and Neuropathy Study Group of the Italian Society of the Study of Diabetes and Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and HOE 901/3003 study group and German Working Group on Quality Control and Turkish Diabetes Epidemiology Group and Mauritian NCD group and D.I.O.R. study group and Lithuanian Collaborative Group for the Epidemiology of Diabetes and DARTS/MEMO Collaboration and Cerivastatin/Bezafibrate Latin America Study Group and Pramlintide Type 1 Study Group and Non-Invasive Task Force and Childhood Diabetes in Finland Study Group and German Pediat. Working Group and EURODIAB Complications Study Group and Hvidøre Study group on Childhood Diabetes and EURODIAB Prospective Complications Study (PCS) Group and WHO/IDF Patient Empowerment Workshop and AD Morris for the DARTS/MEMO Collaboration and Pramlintide Type 2 Study Group and Finnish Diabetes Prevention Study Group and Service of internal medecine - diabetologia - vascular diseases and UKPDS Group and IGT Research Group and DAIS Project Group and KANWU study group and Cerivastatin Combination Therapy Study Group and GENEDIAB Study Group and TARDIS Steering Committee and UK centres and Rosiglitazone Study Group and GEDEC study group and HIDM investigators and US Study Group of Insulin Glargine in Type 2 DM and European Insulin Aspart Study Group and The TARDIS Steering Committee and UK centres and The Turkish Diabetes Epidemiology Group and The EURODIAB Prospective Complications Study (PCS) Group and The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and The Finnish Diabetes Prevention Study Group
Diabetologia, ISSN 0012-186X, 8/1999, Volume 42, Issue S1, pp. A1 - A330
Journal Article